发明公开
- 专利标题： BIOMARKER FOR PREDICTING THERAPEUTIC RESPONSIVENESS TO IMMUNE CELL THERAPEUTIC AGENT
-
申请号： EP20893105.5申请日： 2020-11-10
-
公开(公告)号： EP4067506A1公开(公告)日： 2022-10-05
- 发明人: HWANG, So Hyun , LIM, Jae Joon , CHA, Kwang Yul , AN, Hee Jung , KANG, Hae Youn , CHO, Kyung Gi , HEO, Jin Hyung , JOUNG, Je-Gun , KIM, Se Wha , KWON, Ah Young
- 申请人： Sungkwang Medical Foundation
- 申请人地址： KR Seoul 06135 566 Nonhyeon-ro Gangnam-gu
- 代理机构： Weickmann, Hans
- 优先权： KR20190156436 20191129
- 国际公布： WO2021107452 20210603
- 主分类号： C12Q1/6886
- IPC分类号： C12Q1/6886 ; G01N33/574
摘要：
The disclosure relates to biomarkers for predicting a therapeutic response of a patient to an immune cell therapy. Since gene signatures and markers according to an aspect have an excellent predictive capacity for predicting a patient's therapeutic response to an immune cell therapy, a patient group predicted to exhibit therapeutic effects may be selected to perform an appropriate treatment, and a patient's suffering and costs may be reduced.
信息查询
IPC分类:
